RSCM

Rock Springs Capital Management Portfolio holdings

AUM $1.6B
This Quarter Return
+9.33%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$5.05B
AUM Growth
+$5.05B
Cap. Flow
+$474M
Cap. Flow %
9.39%
Top 10 Hldgs %
27.44%
Holding
165
New
13
Increased
67
Reduced
10
Closed
9

Top Buys

1
AGL icon
Agilon Health
AGL
$284M
2
LENZ
LENZ Therapeutics
LENZ
$66.1M
3
VERV
Verve Therapeutics
VERV
$58M
4
LFST icon
Lifestance Health
LFST
$41.8M
5
NEUE icon
NeueHealth
NEUE
$40.8M

Top Sells

1
FPRX
Five Prime Therapeutics, Inc.
FPRX
$100M
2
AZN icon
AstraZeneca
AZN
$32.3M
3
INSP icon
Inspire Medical Systems
INSP
$20.7M
4
AVIR icon
Atea Pharmaceuticals
AVIR
$19.4M
5
UNH icon
UnitedHealth
UNH
$14M

Sector Composition

1 Healthcare 94.39%
2 Consumer Staples 1.63%
3 Industrials 0.72%
4 Financials 0.11%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
TARA icon
126
Protara Therapeutics
TARA
$120M
$6.76M 0.13% 693,542 +3,600 +0.5% +$35.1K
DSGN icon
127
Design Therapeutics
DSGN
$315M
$6.6M 0.13% 332,050 +4,800 +1% +$95.5K
ADAP
128
Adaptimmune Therapeutics
ADAP
$15.6M
$6.58M 0.13% 1,545,000 – –
TRIL
129
DELISTED
Trillium Therapeutics Inc.
TRIL
$6.1M 0.12% 628,500 +7,700 +1% +$74.7K
FATE icon
130
Fate Therapeutics
FATE
$120M
$6.08M 0.12% 70,000 – –
ATAI icon
131
ATAI Life Sciences
ATAI
$982M
$5.83M 0.12% +315,028 New +$5.83M
GRTX
132
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
$5.59M 0.11% 568,252 – –
EDAP
133
EDAP TMS
EDAP
$84.5M
$5.4M 0.11% +760,900 New +$5.4M
TLPH icon
134
Talphera
TLPH
$11.1M
$5.23M 0.1% 3,788,757 +3,300 +0.1% +$4.55K
BCEL
135
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$3.92M 0.08% 459,830 +5,900 +1% +$50.3K
TPST icon
136
Tempest Therapeutics
TPST
$44M
$3.47M 0.07% +310,161 New +$3.47M
BLSA
137
DELISTED
BCLS Acquisition Corp. Class A Ordinary Shares
BLSA
$3.25M 0.06% 309,000 – –
PSTX
138
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$2.9M 0.06% 289,754 – –
NUVB icon
139
Nuvation Bio
NUVB
$1.02B
$2.25M 0.04% 241,485 -160,603 -40% -$1.5M
EUCRU
140
DELISTED
Eucrates Biomedical Acquisition Corp. Unit
EUCRU
$2.1M 0.04% 206,000 – –
PRDS
141
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
$2.09M 0.04% 209,332 – –
TMPMU
142
DELISTED
Turmeric Acquisition Corp. Unit
TMPMU
$2.07M 0.04% 206,000 – –
JYAC
143
DELISTED
Jiya Acquisition Corp. Class A Common Stock
JYAC
$2.05M 0.04% 206,200 – –
PHICU
144
DELISTED
Population Health Investment Co., Inc. Unit
PHICU
$2.04M 0.04% 201,044 – –
MLTX icon
145
MoonLake Immunotherapeutics
MLTX
$3.54B
$1.6M 0.03% 154,500 – –
NUVB.WS icon
146
Nuvation Bio Inc. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
NUVB.WS
$68M
$348K 0.01% 134,028 – –
WHWK
147
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$84.8M
$225K ﹤0.01% +133,375 New +$225K
INSP icon
148
Inspire Medical Systems
INSP
$2.77B
– – -100,000 Closed -$20.7M
RPRX icon
149
Royalty Pharma
RPRX
$15.6B
– – -80,000 Closed -$3.49M
TGTX icon
150
TG Therapeutics
TGTX
$4.65B
– – -266,520 Closed -$12.8M
3 4 5
6
7